{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "G",
          "position": "1069"
        },
        "variant_string_id": "LRRK2 R1069G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Figure 2 shows WB analysis of E2F1 and DP expression in dLRRK/hLRRK2 transgenic flies relative to controls, suggesting translational dysregulation by pathogenic LRRK2.",
          "judgment": "Yes",
          "reasoning": "The study links pathogenic LRRK2 to translational dysregulation (E2F1/DP) as part of the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Western blot analysis of protein expression in transgenic Drosophila.",
          "judgment": "Yes",
          "reasoning": "WB analysis of E2F1/DP directly models translational dysregulation, a defined pathogenic mechanism of LRRK2."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Values represent EGFP levels in transgenic crosses relative to control from three independent experiments (P<0.0001, n=10).",
          "judgment": "Yes",
          "reasoning": "Three independent experiments with n=10 and statistical significance imply proper controls and replication."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "No explicit mention of variant controls (pathogenic/benign) in the assay.",
          "judgment": "No",
          "reasoning": "No variant controls were used to validate the assay's specificity for pathogenic LRRK2."
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "No OddsPath calculation; statistical significance (P<0.0001) but no variant controls.",
          "judgment": "N/A",
          "reasoning": "No OddsPath reported, but statistical significance supports functional impact."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The LRRK2 R1069G variant shows significant functional impact on E2F1/DP expression (P<0.0001, n=10) in transgenic Drosophila, consistent with pathogenic mechanisms. However, lack of variant controls limits strength to PS3_supporting."
    }
  ]
}